The VIC Fellows Program offers experienced professionals the opportunity to learn how to identify and evaluate high-potential innovations from around the world. We’re proud to showcase the members of the 2025–2026...
VIC Tech is pleased to announce the appointment of Alex Cameron to its Strategic Advisory Board (SAB). Alex is a globally experienced life sciences executive with a proven track record of launching innovative products,...
Cellia Science a biotechnology company advancing rapid, cell-based diagnostic technologies, announced today that it has been awarded a $306,872 Small Business Innovation Research (SBIR) Phase I grant from the National...
Enhance Diagnostics, announced today that it has been awarded a $307,000 Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Child Health and Human Development (NICHD), part of the...
VIC Tech, a venture studio building life science companies from university and federal lab innovations, announced today the appointment of Dr. Jeff White to its Strategic Advisory Board (SAB). A seasoned life science...
Solaris Vaccines, a biotechnology company pioneering a novel approach to vaccine development, announced the appointment of Taru Dutt, PhD, as Director of Bacterial Countermeasures. This strategic addition strengthens...
In 2024, the University of Lausanne licensed its technology into i-Seq Biotechnology, Inc., a company formed by VIC Tech to advance novel, broad-spectrum vaccines and therapeutics against infectious disease pathogens...
Solaris Vaccines, a biotechnology company pioneering a novel approach to vaccine development, announced the addition of an accomplished scientist to its leadership team. Jonathan O. Rayner, PhD, joins as Chief...
The VIC Tech investment model is unique, sourcing promising life science innovations directly from universities nationwide. It provides funding to launch startup companies and advance these technologies, ultimately...
VIC Tech achieved key milestones in H1 2025, including portfolio advancements, strategic partnerships, and talent development. We remain focused on FDA submissions, clinical trials, and scaling initiatives to drive...
FEATURED RESOURCES
